ARCHIVES

June Panel Meeting Dropped

This article is from The Cancer Letter archive.

Vol. 03 No. 22 | June 3, 1977

Download PDF Visit The Full Archive

Related Articles

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

Analysis Finds Exercise Lowers Colon Cancer Risk

February 27, 2009

Stop Cancer Foundation’s Future In Question, May Not Deliver All Of Funds Promised to NCI

January 18, 1991

Fraumeni Appointed field Studies Chief

January 18, 1980

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002